Mesocarb
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Image:Mesocarb.png | |
| Mesocarb
| |
| Systematic (IUPAC) name | |
| Anilino-((3-(1-phenylpropan-2-yl)-1-oxa-2-aza -3-azoniacyclopenta-2,4-dien-5-yl)imino)methanolate | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C18H18N4O2 |
| Mol. mass | 322.361 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | hepatic |
| Half life | ? |
| Excretion | renal |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status |
Class C (UK), Schedule III (USA) |
| Routes | ? |
Mesocarb (Sidnocarb, Sydnocarb) is a stimulant drug which was developed in the USSR in the 1970s. [1] It has been shown to act as a dopamine reuptake inhibitor[1][1] which is slower acting but longer lasting and less neurotoxic than dextroamphetamine.[1]
Mesocarb is still used for a variety of applications,[1] including counteracting the sedative effects of benzodiazepine drugs,[1] increasing workload capacity and cardiovascular function,[1] treatment of ADHD and hyperactivity in children,[1][1] as a nootropic,[1] and as a drug to enhance resistance to extremely cold temperatures.[1][1] It is also listed as having antidepressant and anticonvulsant properties.
Mesocarb is sold in Russia as 5 milligram tablets under the brand name Sydnocarb. Hydroxylated metabolites can be detected in urine for up to 10 days after consumption, reflecting a relatively long half-life.[1]
Mesocarb is almost unknown in the western world and is neither used in medicine or studied scientifically to any great extent outside Russia and other countries in the former Soviet Union. It has however been added to the list of drugs under international control and is illegal in most countries, despite its multiple therapeutic applications and the lack of significant abuse potential seen in clinical practice.[1]
References
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
